WTAP-mediated N 6-methyladenosine modification of NLRP3 mRNA in kidney injury of diabetic nephropathy
Abstract Background Diabetic nephropathy (DN) is prevalent in patients with diabetes. N 6-methyladenosine (m6A) methylation has been found to cause modification of nucleotide-binding oligomerization domain, leucine-rich repeat, and pyrin domain-containing (NLRP) 3, which is involved in cell pyroptos...
Main Authors: | Jianzi Lan, Bowen Xu, Xin Shi, Qi Pan, Qing Tao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-06-01
|
Series: | Cellular & Molecular Biology Letters |
Subjects: | |
Online Access: | https://doi.org/10.1186/s11658-022-00350-8 |
Similar Items
-
Dynamics of N6-methyladenosine modification during Alzheimer's disease development
by: Shuai Gao, et al.
Published: (2024-03-01) -
WTAP regulates autophagy in colon cancer cells by inhibiting FLNA through N6-methyladenosine
by: Liang Huang, et al.
Published: (2023-12-01) -
WTAP affects intracranial aneurysm progression by regulating m6A methylation modification
by: Yuan Xuesong, et al.
Published: (2023-10-01) -
The Emerging, Multifaceted Role of WTAP in Cancer and Cancer Therapeutics
by: Guomin Ju, et al.
Published: (2023-06-01) -
WTAP mediates the anti-inflammatory effect of Astragalus mongholicus polysaccharide on THP-1 macrophages
by: Haijiao Long, et al.
Published: (2022-10-01)